Home  |  Contact

UniProtKB/Swiss-Prot Q13635: Variant p.Gly1069Arg

Protein patched homolog 1
Gene: PTCH1
Variant information

Variant position:  1069
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Glycine (G) to Arginine (R) at position 1069 (G1069R, p.Gly1069Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Basal cell nevus syndrome (BCNS) [MIM:109400]: An autosomal dominant disease characterized by nevoid basal cell carcinomas and developmental abnormalities such as rib and craniofacial alterations, polydactyly, syndactyly, and spina bifida. In addition, the patients suffer from a multitude of tumors like basal cell carcinomas, fibromas of the ovaries and heart, cysts of the skin, jaws and mesentery, as well as medulloblastomas and meningiomas. {ECO:0000269|PubMed:11231326, ECO:0000269|PubMed:15459969, ECO:0000269|PubMed:8840969, ECO:0000269|PubMed:8981943, ECO:0000269|PubMed:9620294}. Note=The disease may be caused by mutations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In BCNS.
Any additional useful information about the variant.



Sequence information

Variant position:  1069
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1447
The length of the canonical sequence.

Location on the sequence:   NPWTAGIIVMVLALMTVELF  G MMGLIGIKLSAVPVVILIAS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIAS

Mouse                         NPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIAS

Chicken                       NPWTAGIIVVVLALMTVELFGMMGLIGIKLSAVPVVILIAS

Zebrafish                     NPWTAGVIVFILPMMTVELFGIMGLIGIKLSAIPVVILIAS

Caenorhabditis elegans        NPWAALMVVCILGIMTCELAGFMGLVGIKLNPVSAVTLITA

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1447 Protein patched homolog 1
Transmembrane 1056 – 1076 Helical
Helix 1050 – 1074


Literature citations

Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident.
Wicking C.; Shanley S.; Smyth I.; Gillies S.; Negus K.; Graham S.; Suthers G.; Haites N.; Edwards M.; Wainwright B.J.; Chenevix-Trench G.;
Am. J. Hum. Genet. 60:21-26(1997)
Cited for: VARIANTS BCNS TYR-513 AND ARG-1069;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.